Insider trade

Director sold ~$608K of ROIV shares in the open market

Traded Oct 1, 2026 · Filed Oct 6, 2026

~$608K
Reported value · 17K sh @ $36.08: 16K
Holds after · shares reported: +0.8%
stock since the trade · S&P 500 +1.4%, $35.50 → $35.78 on Oct 5

Why it stands out

A board member of Roivant Sciences sold $608K of Roivant Sciences shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Oct 1, 2026
Reporting period: Not applicable
Filed with the SEC: Oct 6, 2026

Director$500K–$1MPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$607,948

Shares × reported transaction price

Timing vs results

56 days after results of Aug 6, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $35.50 on Oct 1, 2026, 121% above its 52-week low and 15% below its high, after a 5% drop over the previous 30 trading days

52-week range $16.03 (Oct 8, 2025) to $41.81 (Sep 9, 2026), 76% of the way up, from 249 adjusted closes. 30 trading days earlier: $37.40 on Aug 19, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001807359-26-000018
Filed / recorded: Oct 6, 2026, 2:05 AM UTC
Added to OQRO: Oct 6, 2026, 8:46 PM UTC
Parser: form4-xml-v2
Data quality: Verified: identifiers matched exactly
Issuer: Roivant Sciences Ltd.
Issuer CIK: 1635088
Ticker: ROIV
Reporting person: Melissa B, Epperly
Relationship: Director
Security: Common Shares
Table: Non-derivative (Table I)
Transaction date: Oct 1, 2026
Transaction code: S
Shares / units: 16,850
Price per share: $36.08
Acquired / disposed: Disposed (D)
Shares owned after: 15,854
Ownership form: Direct
Amendment: No

Footnotes from the filing

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.46 to $36.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on March 30, 2026.

Around the same time

18KShares · @ $4.46

yesterday

Derivative exercise or conversion — not an open-market buy.

More Official record

Director sold ~$33K of Roivant Sciences

Scheduled in advanceyesterday

18KDerivative units

yesterday

Derivative exercise or conversion — not an open-market buy.

More Official record